Literature DB >> 6137770

Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies.

W A Valente, P Vitti, C M Rotella, M M Vaughan, S M Aloj, E F Grollman, F S Ambesi-Impiombato, L D Kohn.   

Abstract

We used a strain of differentiated rat-thyroid cells in continuous culture (the FRTL-5 strain) to detect the presence of growth-promoting antibodies in serum samples from patients with autoimmune thyroid disease. We found that IgG preparations from 17 of 20 patients (85 per cent) with active Graves' disease and two of five patients (40 per cent) with Hashimoto's thyroiditis could augment thyroid-cell growth. In parallel with IgG-induced elevations in intracellular cyclic AMP levels in the same cell line, all 20 of the patients with active Graves' disease had thyroid-stimulatory antibodies. Patients' IgG preparations fell into three subclasses: those with both potent cyclic AMP stimulation and potent growth-promoting activity; those with potent cyclic AMP stimulation but low-level growth promotion; and those with potent growth promotion and low-level cyclic AMP action. Growth-promoting antibodies were not detected in patients with Graves' disease in remission (seven patients), nodular goiter (seven), subacute thyroiditis (five), or atrophic thyroiditis (one). Simultaneous assays of growth promotion and cyclic AMP stimulation may be useful in the care of patients with autoimmune thyroid disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137770     DOI: 10.1056/NEJM198310273091705

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

1.  Morphological demonstration and quantification of TSH binding sites in neoplastic and non-neoplastic thyroid tissues. An autoradiographic study using 125I-labelled thyrotropin.

Authors:  S Schröder; H W Müller-Gärtner; R Schroiff; P Schmiegelow; A Niendorf; W Böcker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves' disease.

Authors:  A W Kung; J T Ma; C Wang; R T Young
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

3.  Nodular goiter: effects of surgery and thyroxine medication.

Authors:  K Westermark; C P Persson; H Johansson; F A Karlsson
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

4.  Thyroid growth stimulating activity in highly purified IgG-fractions of patients with nonimmune thyroid diseases.

Authors:  M D Oethinger; B E Wenzel; P C Scriba
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

5.  The influence of remnant size, antithyroid antibodies, thyroid morphology, and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism.

Authors:  E Jörtsö; S Lennquist; B Lundström; K Norrby; S Smeds
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

6.  Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.

Authors:  M Zakarija; S Jin; J M McKenzie
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

7.  Autoimmune alternating hypo- and hyperthyroidism in children.

Authors:  Revi P Mathew; Daniel J Moore
Journal:  Clin Pediatr (Phila)       Date:  2011-06-23       Impact factor: 1.168

8.  Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.

Authors:  E Laurent; J Van Sande; M Ludgate; B Corvilain; P Rocmans; J E Dumont; J Mockel
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

9.  The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.

Authors:  L Bartalena; E Masiello; F Magri; G Veronesi; E Bianconi; F Zerbini; M Gaiti; E Spreafico; D Gallo; P Premoli; E Piantanida; M L Tanda; M Ferrario; P Vitti; L Chiovato
Journal:  J Endocrinol Invest       Date:  2016-07-27       Impact factor: 4.256

10.  Expression of various MHC class II molecules and of intracellular adhesion molecule-1 (ICAM-1) on focal clusters of dendritic cells in iodine deficiency goitres.

Authors:  P Dimal; M Wilders-Truschnig; P Mooij; G Leb; O Eber; W Langsteger; J Hebenstreit; A Beham; C Stiegler; G Dohr
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.